SEC-sourced researchBeta
FBIO
Fortress Biotech, Inc.
Company comparison ↗
Data passport
- CIK
- 0001429260
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Oct 1, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 57,675,000.0000 | Mar 31, 2026 |
| December 2025 | 63,262,000.0000 | Mar 31, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 63,262,000.0000 | 6,815,000.0000 | -65,777,000.0000 | 185,548,000.0000 | 123,365,000.0000 | Mar 31, 2026 |
| December 2024 | 57,675,000.0000 | -45,997,000.0000 | -80,191,000.0000 | 144,223,000.0000 | 145,867,000.0000 | Mar 31, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $63.26M | December 2025 | Mar 31, 2026 | 10-K |
| Previous period revenueRevenues | $57.68M | December 2024 | Mar 31, 2026 | 10-K |
| Net incomeNetIncomeLoss | $6.82M | December 2025 | Mar 31, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$65.78M | December 2025 | Mar 31, 2026 | 10-K |
| Total assetsAssets | $185.55M | December 2025 | Mar 31, 2026 | 10-K |
| Total liabilitiesLiabilities | $123.37M | December 2025 | Mar 31, 2026 | 10-K |